Table 1 Baseline characteristics of participants
Parameter | Overall (n = 490) | Survivors (n = 313) | Non-survivors (n = 177) | P |
|---|---|---|---|---|
Age, year, median(IQR) | 80(16) | 78(17) | 82(15) | 0.012 |
Male, n(%) | 293(59.8) | 183(62.5) | 110(37.5) | 0.425 |
BMI, kg/m2, mean (SD) | 23.0(3.7) | 23.0(3.8) | 22.4(4.1) | 0.093 |
Temperature, ℃, median(IQR) | 36.5(1.7) | 36.5(1.7) | 36.5(1.7) | 0.991 |
Heart rate, times/min, median(IQR) | 97(30) | 95(31) | 102(32) | 0.002 |
Respiratory rate, times/min, median(IQR) | 18(4) | 18(3) | 18(4) | 0.053 |
MAP, mmHg, median(IQR) | 91.3(23.8) | 93.7(24.3) | 86.7(26.3) |  < 0.001 |
SpO2, %, median(IQR) | 95(10) | 95(9) | 92(13) | 0.016 |
ESMcsa, cm2, mean(SD) | 26.0(11.3) | 27.8(11.1) | 22.1(9.22) |  < 0.001 |
Hypertension (n,%) | 293(59.8) | 193(65.9) | 100(34.1) | 0.263 |
Diabetes mellitus (n,%) | 180(36.7) | 126(70) | 54(30) | 0.032 |
Coronary artery disease (n,%) | 166(33.9) | 105(63.3) | 61(36.7) | 0.837 |
Chronic kidney disease | 93(19.0) | 60(64.5) | 33(35.5) | 0.887 |
Cerebrovascular disease | 144(29.4) | 81(56.3) | 63(43.7) | 0.023 |
Chronic liver disease | 21(4.3) | 16(76.2) | 5(23.8) | 0.230 |
Chronic pulmonary disease | 89(18.2) | 65(73) | 24(27) | 0.047 |
Cancer | 84(17.1) | 43(51.2) | 41(48.8) | 0.008 |
GCS, median(IQR) | 15(7) | 15(4) | 9(10) |  < 0.001 |
Barthel index, median(IQR) | 53(75) | 60(70) | 30(70) |  < 0.001 |
CFS, median(IQR) | 6(3) | 6(3) | 7(2) |  < 0.001 |
CURB-65, median(IQR) | 3(1) | 2(1) | 3(2) |  < 0.001 |
PSI, mean(SD) | 137(32) | 128(27) | 153(35) |  < 0.001 |
APACHEII, median(IQR) | 16(8) | 14(7) | 20(10) |  < 0.001 |
SOFA, median(IQR) | 5(4) | 4(3) | 7(4) |  < 0.001 |